<DOC>
	<DOCNO>NCT01898923</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy new treatment WH-1 ointment compare Aquacel® Hydrofiber® dressing , apply chronic diabetic foot ulcer 16 weeks.An additional objective study collect safety information include adverse event clinical laboratory abnormality .</brief_summary>
	<brief_title>Evaluate Efficacy Safety WH-1 Ointment Treatment Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description>This trial design randomize , evaluator blind , active-controlled , multi-center study compare efficacy safety WH-1 ointment Aquacel® Hydrofiber® dress treatment diabetic foot ulcer . Independent evaluator blind subject ' treatment evaluate whether wound heal . Eligible subject randomize receive either WH-1 ointment Aquacel® Hydrofiber® dress 1:1 allocation . The study treatment apply select ulcer maximum period 16 week , wound/ulcer closure ( wound size 0 ) two consecutive visit least 2 week apart , subject exit study treatment failure . After , subject regardless wound heal end comparison period follow 12 week investigate durability . During follow-up period , Aquacel® Hydrofiber® dress applied subject unhealed recurrent wound . Each target ulcer wound photograph blind assessment monitor scheduled visit . One interim analysis plan around 50 % study information ; final analysis conduct end study .</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Inclusion Criteria 1 . Has sign write informed consent prior first study evaluation ; 2 . Male female least 20 &lt; 80 year age ; 3 . Diabetes mellitus ( type 1 2 ) HbA1c &lt; 12.0 % measure screening within three month prior randomization ; 4 . An ankle brachial index target limb least 0.8 measured screening within three month prior randomization ; 5 . The target ulcer must follow characteristic : Grade 1 2 per Wagner Ulcer Classification System ; No high ankle ; Noinfected ; A crosssectional area 1 25 cm2 postdebridement ; Present least 4 week randomization ; 6 . If female childbearing potential negative pregnancy test neither breastfeeding intending become pregnant study ; 7 . Able willing attend schedule visit comply study procedure . 1 . Presence necrosis , purulence sinus tracts remove debridement ; 2 . Acute Charcot 's neuroarthropathy determine clinical and/or radiographic examination ; 3 . Has undergone revascularization procedure aim increase blood flow treatment target limb &lt; 4 week prior randomization ; 4 . Poor nutritional status define albumin &lt; 2.5 g/dL ; 5 . Aspartate Aminotransferase ( AST , GOT ) and/or Alanine Aminotransferase ( ALT , GPT ) &gt; 3 x normal upper limit ; 6 . Serum Creatinine &gt; 2 x normal upper limit ; 7 . Treatment immunosuppressive chemotherapeutic agent , radiotherapy systemic corticosteroid le 4 week randomization ; 8 . Use investigational drug therapy within 4 week prior randomization ; 9 . A psychiatric condition ( e.g. , suicidal ideation ) , current chronic alcohol drug abuse problem , determine subject 's medical history , , opinion Investigator , may pose threat subject compliance ; 10 . Judged investigator suitable study reason .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>WH-1 , Diabetic Foot , Ulcer</keyword>
</DOC>